Strategies to Reduce the Tampering and Subsequent Abuse of Long-acting Opioids: Potential Risks and Benefits of Formulations With Physical or Pharmacologic Deterrents to Tampering
- 1 July 2012
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 87 (7) , 683-694
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended releaseDrug Design, Development and Therapy, 2011
- Age and Gender Trends in Long-Term Opioid Analgesic Use for Noncancer PainAmerican Journal of Public Health, 2010
- Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid UsersClinical Drug Investigation, 2009
- Prescription Opioid Abuse and Diversion in an Urban Community: The Results of an Ultrarapid AssessmentPain Medicine, 2009
- The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusersDrug and Alcohol Dependence, 2008
- Validation of the Revised Screener and Opioid Assessment for Patients With Pain (SOAPP-R)The Journal of Pain, 2008
- OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelinesOsteoarthritis and Cartilage, 2008
- Development and validation of the Current Opioid Misuse MeasurePain, 2007
- Survey of select practice behaviors by primary care physicians on the use of opioids for chronic painCurrent Medical Research and Opinion, 2006
- Primary care provider concerns about management of chronic pain in community clinic populationsJournal of General Internal Medicine, 2006